Basic Information
Dash Bio is a developer of a clinical bioanalytical platform designed to provide technical support services for drug development. The company's platform adopts a technology-first approach to develop key services throughout the entire drug development lifecycle, aiming to build new capabilities that utilize artificial intelligence, robotics, and fully integrated software to deliver GLP-compliant services, enabling users to automate critical steps, reduce costs and time-to-market, without compromising quality.
Dash Bio, Inc.
Boston,Massachusetts,United States of America
less than 15 people
January 01, 2024
--

